TGFB1 and Patent ductus arteriosus: To the best of our knowledge, this is the first report that shows significant changes in gene expression profiles in the TGF-β, MAPK and BMP signaling pathways in patient-derived RNA-seq samples from PDA, based solely on MUC1 expression levels.